Yüklüyor......
Activity measurements of dalcinonacog alfa
INTRODUCTION: Many recombinant and modified FIX products have been, and continue to be, developed with the aim of improving treatment for patients with haemophilia B. One such new product is dalcinonacog alfa, a recombinant FIX with modifications to provide improved features such as subcutaneous adm...
Kaydedildi:
| Yayımlandı: | Haemophilia |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7891335/ https://ncbi.nlm.nih.gov/pubmed/32142203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13949 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|